Department of Diagnostic and Interventional Radiology, Eberhard-Karls-University, Hoppe-Seyler-Str.3, 72076 Tübingen, Germany.
Siemens Healthcare GmbH, Forchheim, Germany.
Eur J Radiol. 2023 Dec;169:111153. doi: 10.1016/j.ejrad.2023.111153. Epub 2023 Oct 18.
To compare image quality of contrast-enhanced abdominal-CT using 1st-generation Dual Source Photon-Counting Detector CT (DS-PCD-CT) versus 2nd-generation Dual-Source Energy Integrating-Detector CT (DS-EID-CT) in patients with BMI ≥ 25, applying two different contrast agent volumes, vendor proposed protocols and different virtual monoenergetic images (VMI).
68 overweight (BMI ≥ 25 kgm) patients (median age: 65 years; median BMI 33.3 kgm) who underwent clinically indicated, portal-venous contrast-enhanced abdominal-CT on a commercially available 1st-generation DS-PCD-CT were prospectively included if they already have had a pre-exam on 2nd-generation DS-EID-CT using a standardized exam protocol. Obesity were defined by BMI-calculation (overweight: 25-29.9, obesity grade I: 30-34.9; obesity grade II: 35-39.9; obesity grade III: > 40) and by the absolute weight value. Body weight adapted contrast volume (targeted volume of 1.2 mL/kg for the 1st study and 0.8 mL/kg for the 2nd study) was applied in both groups. Dual Energy mode was used for both the DS-PCD-CT and the DS-EID-CT. Polychromatic images and VMI (40 keV and 70 keV) were reconstructed for both the DS-EID-CT and the DS-PCD-CT data (termed T3D). Two radiologists assessed subjective image quality using a 5-point Likert-scale. Each reader drew ROIs within parenchymatous organs and vascular structures to analyze image noise, contrast-to-noise ratio (CNR) and signal-to-noise ratio (SNR).
Median time interval between scans was 12 months (Min: 6 months; Max: 36 months). BMI classification included overweight (n = 10, 14.7 %), obesity grade I (n = 38, 55.9 %), grade II (n = 13, 19.1 %) and grade III (n = 7, 10.3 %). The SNR achieved with DS-PCD-CT at QIR level 3was 12.61 vs. 11.47 (QIR 2) vs. 10.53 (DS-EID-CT), irrespective of parenchymatous organs. For vessels, the SNR were 16.73 vs. 14.20 (QIR 2) vs. 12.07 (DS-EID-CT). Moreover, the obtained median noise at QIR level 3 was as low as that of the DS-EID-CT (8.65 vs. 8.65). Both radiologists rated the image quality higher for DS-PCD-CT data sets (p < 0.05). The highest CNR was achieved at 40 keV for both scanners. T3D demonstrated significantly higher SNR and lower noise level compared to 40 keV and 70 keV. Median CTDI and DLP values for DS-PCD-CT and DS-EID-CT were 10.90 mGy (IQR: 9.31 - 12.50 mGy) vs. 16.55 mGy (IQR: 15.45 - 18.17 mGy) and 589.50 mGy * cm (IQR: 498.50 - 708.25 mGy * cm) vs. 848.75 mGy * cm (IQR: 753.43 - 969.58 mGy * cm) (p < 0.001).
Image quality can be maintained while significantly reducing the contrast volume and the radiation dose (27% and 34% lower DLP and 31% lower CDTI) for abdominal contrast-enhanced CT using a 1st-generation DS-PCD-CT. Moreover, polychromatic reconstruction T3D on a DS-PCD-CT enables sufficient diagnostic image quality for oncological imaging.
比较体质量指数(BMI)≥25 的患者使用第一代双源光子计数探测器 CT(DS-PCD-CT)和第二代双源能量积分探测器 CT(DS-EID-CT)行腹部增强 CT 检查时的图像质量,分别应用两种不同的对比剂用量、厂家推荐的协议和不同的虚拟单能量图像(VMI)。
前瞻性纳入 68 例 BMI≥25 kg/m² 的超重(BMI≥25 千克/平方米)患者(中位年龄:65 岁;中位 BMI:33.3 kg/m²),这些患者在商业上可用的第一代 DS-PCD-CT 上进行了临床需要的门脉期增强腹部 CT 检查,如果他们已经在第二代 DS-EID-CT 上进行了使用标准化检查方案的预检查,则符合入选条件。通过 BMI 计算(超重:25-29.9,肥胖 I 级:30-34.9;肥胖 II 级:35-39.9;肥胖 III 级:>40)和绝对体重值来定义肥胖。在两组中均应用体重适应性对比剂用量(第 1 项研究中目标体积为 1.2 ml/kg,第 2 项研究中目标体积为 0.8 ml/kg)。DS-PCD-CT 和 DS-EID-CT 均使用双能模式。对 DS-EID-CT 和 DS-PCD-CT 数据(称为 T3D)均进行多光谱图像和 VMI(40 keV 和 70 keV)重建。两名放射科医生使用 5 分制 Likert 量表评估主观图像质量。每位读者在实质器官和血管结构内绘制 ROI,以分析图像噪声、对比噪声比(CNR)和信噪比(SNR)。
两次扫描之间的中位时间间隔为 12 个月(最短:6 个月;最长:36 个月)。BMI 分类包括超重(n=10,14.7%)、肥胖 I 级(n=38,55.9%)、肥胖 II 级(n=13,19.1%)和肥胖 III 级(n=7,10.3%)。在 QIR 水平 3 时,DS-PCD-CT 的 SNR 为 12.61,而 QIR 2 为 11.47,DS-EID-CT 为 10.53,与实质器官无关。对于血管,SNR 分别为 16.73、14.20(QIR 2)和 12.07(DS-EID-CT)。此外,在 QIR 水平 3 时获得的中位数噪声与 DS-EID-CT 相同(8.65 vs. 8.65)。两位放射科医生均认为 DS-PCD-CT 数据集的图像质量更高(p<0.05)。在两种扫描仪中,最高的 CNR 均在 40 keV 时获得。T3D 与 40 keV 和 70 keV 相比,显示出更高的 SNR 和更低的噪声水平。DS-PCD-CT 和 DS-EID-CT 的 CTDI 和 DLP 中位数分别为 10.90 mGy(IQR:9.31-12.50 mGy)和 16.55 mGy(IQR:15.45-18.17 mGy)和 589.50 mGycm(IQR:498.50-708.25 mGycm)和 848.75 mGycm(IQR:753.43-969.58 mGycm)(p<0.001)。
使用第一代 DS-PCD-CT 行腹部增强 CT 检查时,可在保持图像质量的同时,显著减少对比剂用量和辐射剂量(DLP 降低 27%和 34%,CTDI 降低 31%)。此外,DS-PCD-CT 上的多光谱重建 T3D 可为肿瘤成像提供足够的诊断图像质量。